Work

The role of ELABELA in targeted treatment of acute myeloid leukaemia

Year: 2025

Type: article

Abstract: Acute myeloid leukaemia is a clonal stem cell disease. Various molecular targets are being sought in this disease which has a low chance of cure. However, it is desired that targeted treatments should have few side effects. We tried to understand whether the embryogenic peptide elabela, which has been closely associated with many pathways involved in cancer mechanism, is a peptide worth investigating in targeted treatment of acute myeloid leukaemia.

Source: Journal of Current Hematology & Oncology Research

DOI: 10.51271/jchor-0065

Authors: Didar Yanardağ Açık, Zeynep Tuğba Karabulut

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4413197853

FWCI:

Cites:

Cited by:

Related to: 10